# SCHEDULE Follow Up Visit 5-7 yr

> **NCT02864706** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 95 (actual)

## Conditions studied

- Heart Transplantation

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Cyclosporine
- **DRUG:** Mycophenolate mofetil
- **DRUG:** Corticosteroids

## Key facts

- **NCT ID:** NCT02864706
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-18
- **Primary completion:** 2017-09-25
- **Final completion:** 2017-09-25
- **Target enrollment:** 95 (ACTUAL)
- **Last updated:** 2019-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02864706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02864706, "SCHEDULE Follow Up Visit 5-7 yr". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02864706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*